-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
PP-FR-CN-1010
Past Review 1.Professor Wang Feng| a blockbuster release: From the "intestinal" consideration, grasp the overall situation, standardize the whole process management of colorectal cancer patients 2.
【Talking about bowel cancer】Professor Lin Junzhong| wonderful attack: Perioperative treatment strategies and thoughts of colorectal cancer 3.
【Talking about bowel cancer】Professor | Deng Ting: standardize "adjuvantivity", constantly seek innovation, and discuss the decision-making of adjuvant therapy for colorectal cancer4.
【Talking about bowel cancer】Wonderful Attack| Professor Xue Junli: Focus on immunity, talk about "gut" affairs, opportunities and challenges of colorectal cancer immunotherapy 5.
【Talking about bowel cancer|】Professor Qiu Hong: Take precautions, prepare fully, and focus on the management of common adverse reactions of targeted therapy for colorectal cancer6.
Professor Chen Zhiyu|: Precise diagnosis and treatment, "target" to grasp the future, focus on the exploration of targeted therapy for colorectal cancer
This platform aims to deliver more medical information
to healthcare professionals.
The content published on this platform cannot replace professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice
.
If such information is used for purposes other than understanding medical information, this platform does not assume relevant responsibilities
.
The content published by this platform does not mean that it agrees with its description and views
.
If copyright issues are involved, please contact us and we will deal with it
as soon as possible.